AlphaYouBEAM: Cavanagh Bethany J discloses a sale
By AlphaYouPublished Form 4
Cavanagh Bethany J
Reporting filer
Cavanagh Bethany J reported Sale in Beam Therapeutics Inc.: 187 units of Common Stock, dated 2026-10-01. The full Form 4 contains 1 transaction entry.
- Disclosed
- Oct 2, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Cavanagh Bethany J | 2026-10-01 | S | Sale | 187 | 24.41 | 50,984 | 1 day | Filed terms
|
Common Stock
- Owner
- Cavanagh Bethany J
- Date
- 2026-10-01
- Code
- S
- Action
- Sale
- Quantity
- 187
- Price
- 24.41
- Following holdings
- 50,984
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-01
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: false
- id: F1
- transaction Shares: 187
- transaction Price Per Share: 24.41
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 50984
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Cavanagh Bethany J: SVP, Finance and Treasurer.
- The filing reports a Rule 10b5-1 trading plan.
- F1: These shares of common stock were automatically sold in a non-discretionary transaction by the Reporting Person in order to cover tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. 2019 Equity Incentive Plan on September 30, 2024. The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 9, 2024.
Original sources
Prepared automatically from public filing data. Report a correction.